Neoadjuvant and adjuvant therapy of non-small cell lung cancer

This publication has 47 references indexed in Scilit:

• Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2002
• Genetic Analysis of the -Tubulin Gene, TUBB, in Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2001
• Neoadjuvant therapy with Docetaxel (TAX) and Cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicities
  Lung Cancer, 2000
• French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)
  Lung Cancer, 2000
• Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non-small Cell Lung Cancer^†
  Japanese Journal of Cancer Research, 1999
• Systematic nodal dissection in the intrathoracic staging of patients with non–small cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 1999
• Results of cancer and leukemia group B protocol 8935
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• Nucleotide excision repair II: from yeast to mammals
  Trends in Genetics, 1993
• Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus
  European Journal of Cardio-Thoracic Surgery, 1990